Your browser doesn't support javascript.
loading
A Case of Confirmed Ceftriaxone-induced Immune Thrombocytopenia.
Piedra Abusharar, Shady; Shah, Neal; Patel, Ravi; Jain, Rohit; Polimera, Hyma V.
Afiliación
  • Piedra Abusharar S; Internal Medicine, Penn State College of Medicine/ Penn State Health Milton S. Hershey Medical Center, Hershey, USA.
  • Shah N; Internal Medicine, Penn State Health Milton S. Hershey Medical Center, Hershey, USA.
  • Patel R; Internal Medicine, Penn State Health Milton S. Hershey Medical Center, Hershey, USA.
  • Jain R; Internal Medicine, Penn State Health Milton S. Hershey Medical Center, Hershey, USA.
  • Polimera HV; Internal Medicine, Penn State Health Milton S. Hershey Medical Center, Hershey, USA.
Cureus ; 11(5): e4688, 2019 May 17.
Article en En | MEDLINE | ID: mdl-31338265
Drug-induced immune thrombocytopenia (DITP) is a rare, but potentially fatal cause of isolated thrombocytopenia. DITP is thought to occur when drug-dependent antibodies bind to the platelet membrane glycoproteins to activate platelet consumption signaling. Common implicated drugs include quinine/quinidine, penicillamines, valproic acid and cotrimoxazole. Ceftriaxone is a rare culprit with only six reported cases since 1991, of which only three were confirmed with drug-dependent antiplatelet antibodies. We describe a case of antibody confirmed ceftriaxone-induced immune thrombocytopenia after initiation of empiric antibiotic therapy for acute bacterial meningitis.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Cureus Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Cureus Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos